Hayden Donald J Jr - Net Worth and Insider Trading
Hayden Donald J Jr Net Worth
The estimated net worth of Hayden Donald J Jr is at least $2 Million dollars as of 2024-04-27. Hayden Donald J Jr is the Director of Insmed Inc and owns about 62,197 shares of Insmed Inc (INSM) stock worth over $2 Million. Hayden Donald J Jr is the Director of Amicus Therapeutics Inc and owns about 5,814 shares of Amicus Therapeutics Inc (FOLD) stock worth over $59,768. Hayden Donald J Jr is also the Director of Theseus Pharmaceuticals Inc and owns about 10,000 shares of Theseus Pharmaceuticals Inc (THRX) stock worth over $40,600. Besides these, Hayden Donald J Jr also holds Regenxbio Inc (RGNX) , Vitae Pharmaceuticals Inc (VTAE) . Details can be seen in Hayden Donald J Jr's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Hayden Donald J Jr has not made any transactions after 2022-12-30 and currently still holds the listed stock(s).
Transaction Summary of Hayden Donald J Jr
Hayden Donald J Jr Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hayden Donald J Jr owns 6 companies in total, including Regenxbio Inc (RGNX) , Insmed Inc (INSM) , and Amicus Therapeutics Inc (FOLD) among others .
Click here to see the complete history of Hayden Donald J Jr’s form 4 insider trades.
Insider Ownership Summary of Hayden Donald J Jr
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RGNX | Regenxbio Inc | 2020-02-10 | director |
INSM | Insmed Inc | 2019-04-09 | director |
FOLD | Amicus Therapeutics Inc | 2018-01-02 | director |
VTAE | Vitae Pharmaceuticals Inc | 2016-10-25 | director |
BMY | Bristol-Myers Squibb Co | 2003-09-10 | EVP and President & Americas |
THRX | Theseus Pharmaceuticals Inc | 2022-12-30 | director |
Hayden Donald J Jr Latest Holdings Summary
Hayden Donald J Jr currently owns a total of 5 stocks. Among these stocks, Hayden Donald J Jr owns 62,197 shares of Insmed Inc (INSM) as of April 9, 2019, with a value of $2 Million and a weighting of 93.89%. Hayden Donald J Jr owns 5,814 shares of Amicus Therapeutics Inc (FOLD) as of January 2, 2018, with a value of $59,768 and a weighting of 3.64%. Hayden Donald J Jr also owns 10,000 shares of Theseus Pharmaceuticals Inc (THRX) as of December 30, 2022, with a value of $40,600 and a weighting of 2.47%. The other 2 stocks Regenxbio Inc (RGNX) , Vitae Pharmaceuticals Inc (VTAE) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Hayden Donald J Jr
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
INSM | Insmed Inc | 2019-04-09 | 62,197 | 24.80 | 1,542,486 |
FOLD | Amicus Therapeutics Inc | 2018-01-02 | 5,814 | 10.28 | 59,768 |
THRX | Theseus Pharmaceuticals Inc | 2022-12-30 | 10,000 | 4.06 | 40,600 |
RGNX | Regenxbio Inc | 2020-02-10 | 0 | 16.19 | 0 |
VTAE | Vitae Pharmaceuticals Inc | 2016-03-21 | 0 | 21.00 | 0 |
Holding Weightings of Hayden Donald J Jr
Hayden Donald J Jr Form 4 Trading Tracker
According to the SEC Form 4 filings, Hayden Donald J Jr has made a total of 0 transactions in Insmed Inc (INSM) over the past 5 years. The most-recent trade in Insmed Inc is the sale of 6,286 shares on April 9, 2019, which brought Hayden Donald J Jr around $207,375.
According to the SEC Form 4 filings, Hayden Donald J Jr has made a total of 0 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years. The most-recent trade in Amicus Therapeutics Inc is the sale of 20,000 shares on January 2, 2018, which brought Hayden Donald J Jr around $300,000.
According to the SEC Form 4 filings, Hayden Donald J Jr has made a total of 1 transactions in Theseus Pharmaceuticals Inc (THRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Theseus Pharmaceuticals Inc is the acquisition of 10,000 shares on December 30, 2022, which cost Hayden Donald J Jr around $50,000.
More details on Hayden Donald J Jr's insider transactions can be found in the Insider Trading History of Hayden Donald J Jr table.Insider Trading History of Hayden Donald J Jr
- 1
Hayden Donald J Jr Trading Performance
GuruFocus tracks the stock performance after each of Hayden Donald J Jr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hayden Donald J Jr is 55.02%. GuruFocus also compares Hayden Donald J Jr's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hayden Donald J Jr within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Hayden Donald J Jr's insider trading performs compared to the benchmark.
Performance of Hayden Donald J Jr
Average Return
-18.67%
Outperforming Transactions
0%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 153.21 | 55.02 | 87.35 | -18.67 | ||
Relative Return to S&P 500(%) | 148.57 | 49.52 | 71.44 | -42.9 |
Hayden Donald J Jr Ownership Network
Ownership Network List of Hayden Donald J Jr
Ownership Network Relation of Hayden Donald J Jr
Hayden Donald J Jr Owned Company Details
What does Regenxbio Inc do?
Who are the key executives at Regenxbio Inc?
Hayden Donald J Jr is the director of Regenxbio Inc. Other key executives at Regenxbio Inc include director & See Remarks Kenneth T. Mills , Chief Medical Officer Steve Pakola , and See Remarks Vittal Vasista .
Regenxbio Inc (RGNX) Insider Trades Summary
Over the past 18 months, Hayden Donald J Jr made no insider transaction in Regenxbio Inc (RGNX). Other recent insider transactions involving Regenxbio Inc (RGNX) include a net sale of 135,000 shares made by Kenneth T. Mills , and a net sale of 12,878 shares made by Steve Pakola .
In summary, during the past 3 months, insiders sold 57,878 shares of Regenxbio Inc (RGNX) in total and bought 0 shares, with a net sale of 57,878 shares. During the past 18 months, 147,878 shares of Regenxbio Inc (RGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 147,878 shares.
Regenxbio Inc (RGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regenxbio Inc Insider Transactions
Hayden Donald J Jr Mailing Address
Above is the net worth, insider trading, and ownership report for Hayden Donald J Jr. You might contact Hayden Donald J Jr via mailing address: C/o Amicus Therapeutics, Inc., 1 Cedar Brook Drive, Cranbury Nj 08512.